CAPS—A Rare, Lifelong Disease1-3
CAPS is a group of rare, genetic diseases that include Familial Cold Autoinflammatory Syndrome (FCAS) and Muckle-Wells Syndrome (MWS).1-3
Prevalence of CAPS is estimated at 1 in 1 million. Approximately 300 patients are estimated to suffer from CAPS in the United States.2
- CAPS is caused by genetic mutations, often in the NLRP3 (or CIAS1) gene2,3
- These mutations result in overproduction of the proinflammatory cytokine, interleukin-1 beta (IL-1β)1
- Without treatment, debilitating and recurrent symptoms of CAPS can disable patients for hours or last for days4-6
- CAPS can remain undiagnosed and untreated due to the rarity of the disease and the resemblance of symptoms to other conditions2,7
Diagnosing CAPS
CAPS is a challenging differential diagnosis. While symptoms may resemble other illnesses, CAPS symptoms are chronic in nature.8
If a patient reports any of the following symptoms of CAPS on a daily or ongoing basis, or in response to changes in temperature or the environment, a diagnosis of Familial Cold Autoinflammatory Syndrome ( FCAS) or Muckle-Wells Syndrome (MWS) may be considered:
- Urticaria4,5
- Fever or chills4,5
- Headache or migraine5
- Fatigue or malaise4,5
- Conjunctivitis4,5
- Arthralgia4,5
- Myalgia5
- Proper diagnosis of CAPS should include2,5:
CAPS—A Familial Disease
- Genetic mutations in the NLRP3 (or CIAS1) gene are usually autosomal-dominant inherited mutations2,3
- Knowledge of the family connections in CAPS can be valuable to the health of future generations:
- A link to an ancestor with CAPS may be revealed
- Another family member presently suffering from the disease may be diagnosed
Use the downloadable assessment below to help you when identifying and diagnosing CAPS patients in your practice.




![[Image: Novartis]s](/images/nova-btn-logo.jpg)